To investigate if a combined intervention of resistance training and protein supplementation is more effective to prevent or decrease the adverse effects of ADT on body weight and body composition in men with PC compared to training alone or usual…
ID
Source
Brief title
Condition
- Other condition
- Reproductive neoplasms male malignant and unspecified
Synonym
Health condition
spiermassaverlies door androgeen deprivatie therapie bij prostaatakanker
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary study endpoint will be quadriceps cross sectional area (measured by
CT) and muscle strength.
Measurements of cross sectional area and muscle strength will be performed at
baseline and after 5 and 12 months
Secondary outcome
Secondary study endpoints will be body composition (body mass index, waist
circumference, muscle mass, fat mass, body fat distribution), measured by
anthropometrics and DEXA, physical performance, endurance capacity, level of
physical activity, level of independent living, nutritional intake, HRQoL,
fatigue, comorbidity, blood results, muscle characteristics, and compliance.
Measurements of body composition and physical performance will be performed at
baseline and after 5 and 12 months. Questionnaires on level of physical
activity and independent living, fatigue, HRQoL and comorbidity will be taken
at baseline, 5, 12 and 24 months.
Blood samples will be taken at 0, 5 and 12 months. Endurance capacity
(spiroergometry) and muscle characteristics (biopsies) will be measured at 0
and 5 months.
Background summary
Due to the increase of our aging population and the advances in prostate cancer
(PC) treatment, the prevalence of PC patients rises. One of the cornerstones in
PC treatment is the use of androgen deprivation therapy (ADT). Unfortunately,
ADT leads to unfavorable changes in body composition, decreased physical
performance, fatigue and a lower health related quality of life (HRQoL).
Exercise- and nutritional interventions have the potential to diminish the side
effects of ADT treatment. A substantial number of studies in patients with PC
undergoing ADT show positive effects of exercise training on these side
effects. Moreover, studies in elderly have shown that the addition of a protein
supplement can enhance the positive effects of exercise training on lean body
mass, muscle strength and physical performance compared to exercise alone.
However, the usual care of PC patients does not contain a combined exercise and
protein supplementation program yet.
Study objective
To investigate if a combined intervention of resistance training and protein
supplementation is more effective to prevent or decrease the adverse effects of
ADT on body weight and body composition in men with PC compared to training
alone or usual care.
Study design
Randomized placebo controlled trial with three parallel groups.
Intervention
Participants will be randomly assigned to one of the two intervention groups.
The control group will be recruited separately. Both intervention groups
receive high-intensity resistance exercise training under direct personal
supervision (twice a week, for 60 min, during 20 weeks). After 20 weeks, the
patient will be encouraged to continue regular exercise at home or in the
neighbourhood. During the 20 weeks training program participants will receive a
placebo or protein supplement (35 gram protein) immediately after each exercise
session and every evening prior to sleep. Patients in the control group will
receive usual care.
Study burden and risks
In addition to the appointments for usual medical care, all patients will be
asked to spend half a day (morning or afternoon) at 0, 5 and 12 months for
measurements of body composition, physical performace, and questionaires. At 24
months all patients will be asked to spend 30 minutes on filling in
questionnaires. In addition patients will be asked to fill in a food diary (3
days) and to wear an accelerometer (7 days) in the week prior to the
measurements at 0, 5 and 12 months.
Risks as the result of participation in this study are minimal. There are no
complications associated with the procedure of a DEXA and CT scan. The level of
radiation emitted during DEXA and CT scanning is merely a fraction of that
emitted during a transcontinental flight. Muscle biopsies will be taken under
local anaesthesia by an experienced physician, but may cause some minor
discomfort for maximally up to 24 h after completion. The discomfort is
comparable to muscle soreness or the pain one has after bumping into a table.
In rare conditions, the biopsy can lead to local infection or bleeding.
Patients allocated to the intervention groups are supposed to participate in a
20*week exercise program, twice a week for 60 minutes. We expect that the
exercise program will have a beneficial effect on the patients* health status.
As a result of the resistance type exercise training program, participants will
likely experience a gain in muscle mass and strength and a healthy improvement
in body composition. Depending on the baseline level of fitness, this will
result in an increase in functional performance. It is possible that
participants may experience muscle soreness induced by unaccustomed exercise.
The ingested protein and placebo supplements are regular food substances and
therefore part of the normal diet.
Universiteitssingel 50
Maastricht 6229 ER
NL
Universiteitssingel 50
Maastricht 6229 ER
NL
Listed location countries
Age
Inclusion criteria
- Men with proven PC (starting) with ADT which will be continued for at least
6 months
Exclusion criteria
- Patients who are not able to perform basic activities of daily living such as
walking or patients who are suffering from other disabling comorbidity that
seriously hamper physical exercise (e.g. heart failure, chronic obstructive
pulmonary disease (COPD), orthopedic conditions and neurological disorders).
- Patients with allergies to whey protein or lactose intolerance
- Patients who show cognitive disorders or severe emotional instability
- Unable to speak, understand and read the Dutch language
- Estimated life expectancy < 1 year
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL59282.068.16 |
OMON | NL-OMON20332 |